The role of cyclic 3',5'-adenosine monophosphate in neuromuscular transmission.
D000109:Acetylcholine / Q000502:physiology; D000200:Action Potentials; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000628:Aminophylline / Q000494:pharmacology; D001984:Bronchial Neoplasms; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000502:physiology; D002277:Carcinoma; D000242:Cyclic AMP / Q000502:physiology*; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000494:pharmacology; D009132:Muscles / Q000503:physiopathology; D009135:Muscular Diseases / Q000503:physiopathology*; D009157:Myasthenia Gravis / Q000503:physiopathology*; D009469:Neuromuscular Junction / Q000502:physiology*; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D009435:Synaptic Transmission; D013577:Syndrome
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D010656:Phenylephrine; D000628:Aminophylline; D002110:Caffeine; D011433:Propranolol; D000242:Cyclic AMP; D007545:Isoproterenol; D000109:Acetylcholine; D002118:Calcium; D004837:Epinephrine; D010646:Phentolamine